Development and validation of a clinical prediction model for postcontrast acute kidney injury in patients with postoperative acute kidney injury of acute Stanford type A aortic dissection - Top-Institutions - MDSpire

Development and validation of a clinical prediction model for postcontrast acute kidney injury in patients with postoperative acute kidney injury of acute Stanford type A aortic dissection

  • By

  • Weiwei Zhao

  • Min Ge

  • YongQing Cheng

  • Ming Chen

  • Qing Zhou

  • Wenkui Yu

  • July 10, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Ethics Committee of Nanjing Drum Tower Hospital
    Ethics Committee of Nanjing Drum Tower Hospital

    Nanjing, Jiangsu

    Key Differentiators

    • Nephrology

  • #2

    Swedish Society of Uroradiology
    Swedish Society of Uroradiology

    Stockholm, Stockholm

    Key Differentiators

    • Urology

  • #3

    University Heart and Vascular Center Hamburg
    University Heart and Vascular Center Hamburg

    Hamburg, Hamburg

    Key Differentiators

    • Cardiology
    • Nephrology

  • #4

    West China Hospital of Sichuan University
    West China Hospital of Sichuan University

    Chengdu, Sichuan

    Key Differentiators

    • Nephrology

  • #5

    The First Affiliated Hospital of Xinjiang Medical University
    The First Affiliated Hospital of Xinjiang Medical University

    Urumqi, Xinjiang

    Key Differentiators

    • Nephrology

Original Source(s)

Development and validation of a clinical prediction model for postcontrast acute kidney injury in patients with postoperative acute kidney injury of acute Stanford type A aortic dissection

  • by Weiwei Zhao, Min Ge, YongQing Cheng, Ming Chen, Qing Zhou, Wenkui Yu

  • July 10, 2026

Related Content

The unified cardiometabolic disease continuum: mechanistic stages of a single pathophysiological process

Navigating a new era in cardiovascular disease epidemiology: big data, artificial intelligence and the imperative of disability inclusion

A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol